Detalhe da pesquisa
1.
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
Lancet Oncol
; 24(8): 892-902, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429302
2.
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC Cancer
; 22(1): 1213, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434554
3.
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Ther Adv Urol
; 16: 17562872241229876, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425504
4.
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations.
Curr Oncol
; 29(4): 2776-2791, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35448200
5.
Platinum-induced nausea and vomiting in patients treated for head and neck cancer.
Bull Cancer
; 108(5): 449-454, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33814187
6.
Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects.
Eur J Cancer
; 159: 87-97, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742160
7.
How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors.
Ther Adv Med Oncol
; 12: 1758835919897530, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165926
8.
Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics.
Fam Cancer
; 17(3): 451-457, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080081